Prepare for your visit
Jeffrey M Boyko
Vascular Surgery · Parma, OH · NPI 1023061165
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$5,800.61
in general payments reported to CMS, 2019-2025 · $842 in 2025
The $842 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Who reported paying
General payments only, top 6 by amount.
- Bard Peripheral Vascular, INC. $975.76
- Medtronic, INC. $651.14
- Organogenesis INC. $610.87
- Janssen Pharmaceuticals, INC $531.37
- Abbott Laboratories $320.73
- Smith+Nephew, INC. $265.89
Drugs and devices associated with these payments
Endurant Iis Kerecis Surgiclose Treo Abdominal Stent-Graft System Heli-Fx Endoanchor System Jeti All In One Non-Sterile Kit Pico Supera Ct Thrombectomy System Kit Flowtriever Catheter, S Puraply Antimicrobial Xarelto Apligraf
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Jeffrey Boyko listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/1047259/jeffrey-m-boyko